{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:20:59Z","timestamp":1788405659009,"version":"build-2803163510"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Given excellent prostate cancer outcomes, comorbidity management is critical to survivorship. While hormone therapy or androgen deprivation therapy (ADT) is a mainstay of treatment, they can negatively impact quality of life and survivorship through cardiovascular, sexual, and metabolic effects. ADT-induced metabolic syndrome causes impaired glucose tolerance, muscle mass loss, and weight gain. This systematic review examined recent randomized clinical trials (RCTs) investigating the impact of diet and weight management strategies on mitigating ADT-related adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review of RCTs (2015-2025) was performed using PubMed\/Embase following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. To identify how diet and weight management impacts ADT symptoms, search terms included: \u201cprostate cancer,\u201d \u201cdiet,\u201d \u201cnutrition,\u201d \u201cglucagon-like peptide-1 receptor agonists\u201d (GLP-1RA), and \u201cADT.\u201d Risk of Bias 2 (ROB2) and Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tools evaluated RCT quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 2799 publications, 16 met inclusion\/exclusion criteria (range, 23-96 patients\/RCT). No RCTs had a high risk of bias or evaluated GLP-1RA. Outcomes included metabolic labs, body composition, and quality of life. Mediterranean and low-carbohydrate diets with exercise reduced cardiovascular and metabolic risk factors, with variable durability. Creatine trended toward increasing lean muscle mass. Multidisciplinary care and community involvement improved accountability and outcome durability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This comprehensive review of diet and ADT in prostate cancer identified nutritional interventions that were safe, feasible, and may be recommended as part of prostate cancer treatment and survivorship. Future RCTs should evaluate optimal diet duration, longer follow-up, multidisciplinary patient support, and novel anti-metabolic therapies like GLP-1RA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jncics\/pkag014","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:36:06Z","timestamp":1770640566000},"source":"Crossref","is-referenced-by-count":3,"title":["Diet, nutrition, and hormone therapy for prostate cancer: a systematic review with implications for future interventions"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5626-0103","authenticated-orcid":false,"given":"Isabella","family":"Pahulu","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Population Health, Stanford University , Stanford, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5479-8331","authenticated-orcid":false,"given":"Matthew","family":"Calumpit","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Biochemistry, University of Pennsylvania , Philadelphia, PA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8575-1100","authenticated-orcid":false,"given":"Paul","family":"Tominez","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tripler Army Medical Center , Honolulu, HI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-7806","authenticated-orcid":false,"given":"Jonathan J","family":"Shih","sequence":"additional","affiliation":[{"name":"School of Medicine, University of California, San Francisco , San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4154-5978","authenticated-orcid":false,"given":"Sasha","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2199-8805","authenticated-orcid":false,"given":"Nicole V","family":"Deville","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of Nevada, Las Vegas , Las Vegas, NV,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7208-8764","authenticated-orcid":false,"given":"Raynald","family":"Samoa","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology, and Metabolism, City of Hope , Duarte, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-6641","authenticated-orcid":false,"given":"Tannaz","family":"Moin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA,","place":["United States"]},{"name":"Endocrinology Service, Greater Los Angeles Veterans Affairs Healthcare System , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8379-391X","authenticated-orcid":false,"given":"Mina S","family":"Sedrak","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-4174","authenticated-orcid":false,"given":"Luca F","family":"Valle","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA,","place":["United States"]},{"name":"Radiation Oncology Service, Greater Los Angeles Veterans Affairs Healthcare System , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7437-6591","authenticated-orcid":false,"given":"Amar U","family":"Kishan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1841-4143","authenticated-orcid":false,"given":"Patricia A","family":"Ganz","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Fielding School of Public Health, University of California Los Angeles , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8493-3868","authenticated-orcid":false,"given":"Kekoa","family":"Taparra","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA,","place":["United States"]},{"name":"Department of Health Policy and Management, Fielding School of Public Health, University of California Los Angeles , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026042903570886700_pkag014-B1","first-page":"308","article-title":"Cancer treatment and survivorship statistics, 2025","volume":"75","author":"Wagle","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026042903570886700_pkag014-B2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026042903570886700_pkag014-B3","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10555-024-10192-9","article-title":"The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer","volume":"43","author":"Ibrahim","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"2026042903570886700_pkag014-B4","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/S0140-6736(24)01548-4","article-title":"National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990\u20132021, and forecasts up to 2050","volume":"404","author":"Ng","year":"2024","journal-title":"The Lancet"},{"key":"2026042903570886700_pkag014-B5","author":"International Diabetes Federation","year":"2025"},{"key":"2026042903570886700_pkag014-B6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.clgc.2022.01.016","article-title":"Association of obesity and diabetes with prostate cancer risk groups in a multiethnic population","volume":"20","author":"Zhu","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"2026042903570886700_pkag014-B7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12020-024-03886-1","article-title":"Diabetes and obesity: the role of stress in the development of cancer","volume":"86","author":"Avogaro","year":"2024","journal-title":"Endocrine"},{"key":"2026042903570886700_pkag014-B8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/clinem\/dgad450","article-title":"New horizons: epidemiology of obesity, diabetes mellitus, and cancer prognosis","volume":"109","author":"Harborg","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026042903570886700_pkag014-B9","author":"CDC","year":"2025"},{"key":"2026042903570886700_pkag014-B10","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-06-0477","article-title":"Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial","volume":"15","author":"Gong","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026042903570886700_pkag014-B11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000351325","article-title":"Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies","volume":"92","author":"Golabek","year":"2014","journal-title":"Urol Int"},{"key":"2026042903570886700_pkag014-B12","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1002\/ijc.33150","article-title":"Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category","volume":"147","author":"Jochems","year":"2020","journal-title":"Int J Cancer"},{"key":"2026042903570886700_pkag014-B13","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.3390\/cancers13164169","article-title":"Obesity as a risk factor for prostate cancer mortality: a systematic review and dose-response meta-analysis of 280,199 patients","volume":"13","author":"Rivera-Izquierdo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026042903570886700_pkag014-B14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott","year":"2013","journal-title":"European Urology"},{"key":"2026042903570886700_pkag014-B15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"2026042903570886700_pkag014-B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6004\/jnccn.2024.7047","article-title":"Symptom burden and survivorship care for patients with prostate cancer on androgen deprivation therapy","volume":"23","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"2026042903570886700_pkag014-B17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41391-019-0126-5","article-title":"A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial","volume":"22","author":"Freedland","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2026042903570886700_pkag014-B18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.297.9.969","article-title":"Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A to Z weight loss study: a randomized trial","volume":"297","author":"Gardner","year":"2007","journal-title":"JAMA"},{"key":"2026042903570886700_pkag014-B19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/01635589809514691","article-title":"Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen","volume":"31","author":"Tymchuk","year":"1998","journal-title":"Nutr Cancer"},{"key":"2026042903570886700_pkag014-B20","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jamaoncol.2024.4406","article-title":"Diet quality, dietary inflammatory potential, and risk of prostate cancer grade reclassification","volume":"10","author":"Su","year":"2024","journal-title":"JAMA Oncol"},{"key":"2026042903570886700_pkag014-B21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1200\/JCO.24.00608","article-title":"High omega-3, low omega-6 diet with fish oil for men with prostate cancer on active surveillance: the CAPFISH-3 randomized clinical trial","volume":"43","author":"Aronson","year":"2025","journal-title":"J Clin Oncol"},{"key":"2026042903570886700_pkag014-B22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s11136-019-02361-z","article-title":"The effectiveness of lifestyle interventions to reduce side effects of androgen deprivation therapy for men with prostate cancer: a systematic review","volume":"29","author":"Geerkens","year":"2020","journal-title":"Qual Life Res"},{"key":"2026042903570886700_pkag014-B23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11764-009-0114-1","article-title":"The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis","volume":"4","author":"Haseen","year":"2010","journal-title":"J Cancer Surviv"},{"key":"2026042903570886700_pkag014-B24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/s1470-2045(25)00231-1","article-title":"Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol","volume":"26","author":"Gillessen","year":"2025","journal-title":"Lancet Oncol"},{"key":"2026042903570886700_pkag014-B25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"2026042903570886700_pkag014-B26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11255-024-04266-4","article-title":"Effect of GLP-1 receptor agonists on prostate cancer risk reduction: a systematic review and meta-analysis","volume":"57","author":"Sharma","year":"2025","journal-title":"Int Urol Nephrol"},{"key":"2026042903570886700_pkag014-B27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026042903570886700_pkag014-B28","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00125-023-05972-x","article-title":"Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort study","volume":"66","author":"Skriver","year":"2023","journal-title":"Diabetologia"},{"key":"2026042903570886700_pkag014-B29","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026042903570886700_pkag014-B30"},{"key":"2026042903570886700_pkag014-B31","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026042903570886700_pkag014-B32","author":"Savovi\u0107"},{"key":"2026042903570886700_pkag014-B33","volume-title":"The GRADE Handbook","author":"Sch\u00fcnemann","year":"2013"},{"key":"2026042903570886700_pkag014-B34","article-title":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]","author":"Evidence Prime","year":"2015","journal-title":"McMaster Univ"},{"key":"2026042903570886700_pkag014-B35","doi-asserted-by":"crossref","first-page":"e060189","DOI":"10.1136\/bmjopen-2021-060189","article-title":"Effects of a multicomponent resistance-based exercise program with protein, vitamin D and calcium supplementation on cognition in men with prostate cancer treated with ADT: secondary analysis of a 12-month randomised controlled trial","volume":"12","author":"Mundell","year":"2022","journal-title":"BMJ Open"},{"key":"2026042903570886700_pkag014-B36","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.3390\/ijerph19095709","article-title":"Mediterranean style dietary pattern with high intensity interval training in men with prostate cancer treated with androgen deprivation therapy: a pilot randomised control trial","volume":"19","author":"Baguley","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026042903570886700_pkag014-B37","doi-asserted-by":"crossref","first-page":"1534735419893764","DOI":"10.1177\/1534735419893764","article-title":"Effects of a group-mediated cognitive behavioral lifestyle intervention on select social cognitive outcomes in prostate cancer patients undergoing androgen deprivation therapy","volume":"18","author":"Focht","year":"2019","journal-title":"Integr Cancer Ther"},{"key":"2026042903570886700_pkag014-B38","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1080\/01635581.2020.1819348","article-title":"Effects of high-dose vitamin D supplementation on phase angle and physical function in patients with prostate cancer on ADT","volume":"73","author":"Inglis","year":"2021","journal-title":"Nutr Cancer"},{"key":"2026042903570886700_pkag014-B39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pros.24136","article-title":"The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer","volume":"81","author":"Chi","year":"2021","journal-title":"Prostate"},{"key":"2026042903570886700_pkag014-B40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/NCC.0000000000001151","article-title":"Staying strong and healthy during androgen deprivation therapy","volume":"47","author":"Myers","year":"2024","journal-title":"Cancer Nurs"},{"key":"2026042903570886700_pkag014-B41","doi-asserted-by":"crossref","first-page":"730.e9","DOI":"10.1016\/j.urolonc.2021.05.032","article-title":"A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: a randomized phase II study","volume":"39","author":"Pollock","year":"2021","journal-title":"Urol Oncol"},{"key":"2026042903570886700_pkag014-B42","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1249\/MSS.0000000000002682","article-title":"Musculoskeletal responses to exercise plus nutrition in men with prostate cancer on androgen deprivation: a 12-month RCT","volume":"53","author":"Dalla Via","year":"2021","journal-title":"Med Sci Sports Exerc"},{"key":"2026042903570886700_pkag014-B43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/bjc.2015.479","article-title":"Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer","volume":"114","author":"Gilbert","year":"2016","journal-title":"Br J Cancer"},{"key":"2026042903570886700_pkag014-B44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11764-014-0417-8","article-title":"A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer","volume":"9","author":"O\u2019Neill","year":"2015","journal-title":"J Cancer Surviv"},{"key":"2026042903570886700_pkag014-B45","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/cncr.35275","article-title":"High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: a phase 2 RCT","volume":"130","author":"Peppone","year":"2024","journal-title":"Cancer"},{"key":"2026042903570886700_pkag014-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-3022-6","article-title":"Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol","volume":"17","author":"Baguley","year":"2017","journal-title":"BMC Cancer"},{"key":"2026042903570886700_pkag014-B47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jsams.2024.09.002","article-title":"Creatine supplementation does not add to resistance training effects in prostate cancer patients under androgen deprivation therapy: a double-blind randomized trial","volume":"28","author":"Fairman","year":"2025","journal-title":"J Sci Med Sport"},{"key":"2026042903570886700_pkag014-B48","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1249\/MSS.0000000000003095","article-title":"Resistance exercise training increases muscle mass and strength in prostate cancer patients on androgen deprivation therapy","volume":"55","author":"Houben","year":"2023","journal-title":"Med Sci Sports Exerc"},{"key":"2026042903570886700_pkag014-B49","doi-asserted-by":"crossref","first-page":"e030080","DOI":"10.1136\/bmjopen-2019-030080","article-title":"Examining the effects of creatine supplementation in augmenting adaptations to resistance training in patients with prostate cancer undergoing androgen deprivation therapy: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Fairman","year":"2019","journal-title":"BMJ Open"},{"key":"2026042903570886700_pkag014-B50","doi-asserted-by":"crossref","first-page":"e47102","DOI":"10.2196\/47102","article-title":"Effectiveness of a nurse-led mobile-based health coaching program for patients with prostate cancer at high risk of metabolic syndrome: randomized waitlist controlled trial","volume":"12","author":"Lee","year":"2024","journal-title":"JMIR Mhealth Uhealth"},{"key":"2026042903570886700_pkag014-B51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/abm\/kax002","article-title":"Effects of a group-mediated exercise and dietary intervention in the treatment of prostate cancer patients undergoing androgen deprivation therapy: results from the IDEA-P trial","volume":"52","author":"Focht","year":"2018","journal-title":"Ann Behav Med"},{"key":"2026042903570886700_pkag014-B52","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S0007114522003452","article-title":"Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN study","volume":"130","author":"Schmitz-Dr\u00e4ger","year":"2023","journal-title":"Br J Nutr"},{"key":"2026042903570886700_pkag014-B53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0090-4295(02)01579-0","article-title":"Osteoporosis during androgen deprivation therapy for prostate cancer","volume":"60","author":"Smith","year":"2002","journal-title":"Urology"},{"key":"2026042903570886700_pkag014-B54","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2011.38.8850","article-title":"Sarcopenia during androgen-deprivation therapy for prostate cancer","volume":"30","author":"Smith","year":"2012","journal-title":"J Clin Oncol"},{"key":"2026042903570886700_pkag014-B55","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/GME.0000000000000933","article-title":"The Hot Flash Related Daily Interference Scale: cutoffs, minimally important differences, and a revised short version","volume":"24","author":"Hardy","year":"2017","journal-title":"Menopause"},{"key":"2026042903570886700_pkag014-B56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/OAJSM.S123529","article-title":"Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis","volume":"8","author":"Chilibeck","year":"2017","journal-title":"Open Access J Sports Med"},{"key":"2026042903570886700_pkag014-B57","doi-asserted-by":"crossref","first-page":"111791","DOI":"10.1016\/j.nut.2022.111791","article-title":"Influence of age, sex, and type of exercise on the efficacy of creatine supplementation on lean body mass: a systematic review and meta-analysis of randomized clinical trials","volume":"103-104","author":"Delpino","year":"2022","journal-title":"Nutrition"},{"key":"2026042903570886700_pkag014-B58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11764-021-01007-9","article-title":"Body image, self-esteem, and sense of masculinity in patients with prostate cancer: a qualitative meta-synthesis","volume":"16","author":"Bowie","year":"2022","journal-title":"J Cancer Surviv"},{"key":"2026042903570886700_pkag014-B59","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.3390\/nu14204314","article-title":"Barriers and facilitators associated with the adoption of and adherence to a Mediterranean style diet in adults: a systematic review of published observational and qualitative studies","volume":"14","author":"Tsofliou","year":"2022","journal-title":"Nutrients"},{"key":"2026042903570886700_pkag014-B60","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/cancers16081538","article-title":"From diabetes to oncology: glucagon-like peptide-1 (GLP-1) receptor agonist\u2019s dual role in prostate cancer","volume":"16","author":"Alhajahjeh","year":"2024","journal-title":"Cancers"},{"key":"2026042903570886700_pkag014-B61","doi-asserted-by":"crossref","first-page":"1085799","DOI":"10.3389\/fendo.2023.1085799","article-title":"GLP-1 receptor agonists for the treatment of obesity: role as a promising approach","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026042903570886700_pkag014-B62","author":"Hamilton Health Sciences Corporation","year":"2025"},{"key":"2026042903570886700_pkag014-B63","volume-title":"StatPearls","author":"Collins","year":"2025"},{"key":"2026042903570886700_pkag014-B64","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1200\/JCO.2007.10.7094","article-title":"Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors","volume":"25","author":"Demark-Wahnefried","year":"2007","journal-title":"J Clin Oncol"},{"key":"2026042903570886700_pkag014-B65","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jada.2011.09.013","article-title":"Long-term dietary outcomes of the FRESH START intervention for breast and prostate cancer survivors","volume":"111","author":"Christy","year":"2011","journal-title":"J Am Diet Assoc"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkag014\/66967360\/pkag014.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/10\/2\/pkag014\/66967360\/pkag014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/10\/2\/pkag014\/66967360\/pkag014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:01:37Z","timestamp":1777449697000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkag014\/8489142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkag014","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,2,17]]},"article-number":"pkag014"}}